HomeAI · summaries
Storia in 2 fonti
Jubilant Pharmova shares decline 6% after Q1 profits falls 45% YoY
Jubilant Pharmova shares fell after Q1 profit plunged 45% YoY to Rs 56 crore, despite revenue rising 17% to Rs 2,229 crore. The profit decline was attributed to weaker operating profitability and higher depreciation, while strong growth across segments, led by CDMO Sterile Injectables, boosted revenue.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
economictimes.indiatimes.com
Jubilant Pharmova shares decline 6% after Q1 profits falls 45% YoY
Jubilant Pharmova shares fell after Q1 profit plunged 45% YoY to Rs 56 crore, despite revenue rising 17% to Rs 2,229 crore. The profit decline was attributed to weaker operating…
- ·
thehindubusinessline.com
Zydus Lifesciences Q1 profit falls 36% despite revenue growth
Zydus Lifesciences Ltd reported a 36% year-on-year decline in consolidated net profit to ₹939.8 crore for the first quarter of FY27, even as revenue from operations grew 22% to…
